RecruitingACTRN12611000189921

Corneal Collagen Cross-linking (CXL) as an adjunct in the treatment of Microbial Keratitis

In patients with microbial keratitis, is conventional treatment plus corneal collagen cross-linking (CXL) more effective than conventional treatment alone in terms of time to healing, visual results, and secondary interventions required?


Sponsor

Dr Laurence Sullivan

Enrollment

298 participants

Start Date

Aug 22, 2011

Study Type

Interventional

Conditions

Summary

Microbial keratitis is a significant cause of ocular morbidity and visual loss, as well as a significant health cost to the community. Ultraviolet light is known to be microbicidal. We think it is likely that the proposed treatment will lead to quicker recovery from this serious eye infection and better visual outcomes.


Eligibility

Sex: Both males and females

Inclusion Criteria1

  • presumed or confirmed microbial keratitis of moderate severity or worse

Exclusion Criteria2

  • Pregnancy
  • impending or actual corneal perforation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

riboflavin 0.1% indextran solution is applied to the cornea every 2 minutes for 30 minutes, and then ultraviolet A light at 365nm and 3 watts/cm2 exposure is applied for a further 30 minutes

riboflavin 0.1% indextran solution is applied to the cornea every 2 minutes for 30 minutes, and then ultraviolet A light at 365nm and 3 watts/cm2 exposure is applied for a further 30 minutes


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000189921


Related Trials